BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6165865)

  • 1. Studies of the nuclear 5 alpha-reductase of human hyperplastic prostatic tissue.
    Hudson RW
    J Steroid Biochem; 1981 Jun; 14(6):579-84. PubMed ID: 6165865
    [No Abstract]   [Full Text] [Related]  

  • 2. Testosterone 5 alpha-reductase and the accumulation of dihydrotestosterone in benign prostatic hyperplasia.
    Cowan RA; Cook B; Cowan SK; Grant JK; Sirett DA; Wallace AM
    J Steroid Biochem; 1979 Jul; 11(1B):609-13. PubMed ID: 90753
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of the nuclear 5 alpha-reductase of human prostatic tissue: comparison of enzyme activities in hyperplastic, malignant, and normal tissues.
    Hudson RW; Moffitt PM; Owens WA
    Can J Biochem Cell Biol; 1983 Jul; 61(7):750-5. PubMed ID: 6194868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of nuclear 5 alpha-reductase activities in the stromal and epithelial fractions of human prostatic tissue.
    Hudson RW
    J Steroid Biochem; 1987 Mar; 26(3):349-53. PubMed ID: 2438480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferences of zearalenone, zearalanol or estradiol-17 beta with the steroid-metabolizing enzymes of the human prostate gland.
    Thouvenot D; Morfin RF
    J Steroid Biochem; 1980 Nov; 13(11):1337-45. PubMed ID: 6161277
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence that human prostatic 5 alpha-reductase is located exclusively in the nucleus.
    Houston B; Chisholm GD; Habib FK
    FEBS Lett; 1985 Jun; 185(2):231-5. PubMed ID: 3996600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal 5 alpha-reductase activity is elevated in benign prostatic hyperplasia.
    Wilkin RP; Bruchovsky N; Shnitka TK; Rennie PS; Comeau TL
    Acta Endocrinol (Copenh); 1980 Jun; 94(2):284-8. PubMed ID: 6158242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5 alpha-reductase activity in stroma and epithelium of rat prostate and epididymis. A contribution to elucidation of the mechanism for development of hyperplastic growth of prostatic tissue.
    Djøseland O; Bruchovsky N; Rennie PS; Otal N; Høglo S
    Acta Endocrinol (Copenh); 1983 Jun; 103(2):273-81. PubMed ID: 6190338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the nuclear 5 alpha-reduction of testosterone and androstenedione in human prostatic carcinoma and benign prostatic hyperplasia.
    Hudson RW; Wherrett D
    J Steroid Biochem; 1990 Feb; 35(2):231-6. PubMed ID: 1689784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of 5 alpha-reductase and 3 alpha(beta)-hydroxysteroid dehydrogenase activities in the hyperplastic human prostate gland.
    Habib FK; Beynon L; Chisholm GD; Busuttil A
    Steroids; 1983 Jan; 41(1):41-53. PubMed ID: 6197780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of zinc on androgen metabolism in the human hyperplastic prostate.
    Wallace AM; Grant JK
    Biochem Soc Trans; 1975; 3(4):540-2. PubMed ID: 1183718
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of androgens in human hyperplastic prostate: evidence for a differential localization of the enzymes involved in the metabolism.
    Abalain JH; Quemener E; Carre JL; Simon B; Amet Y; Mangin P; Floch HH
    J Steroid Biochem; 1989; 34(1-6):467-71. PubMed ID: 2483221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of androstenedione 5 alpha-reductase in epithelium and stroma of human prostate.
    Weisser H; Krieg M
    Steroids; 1997; 62(8-9):589-94. PubMed ID: 9432753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of testosterone by principal cells and basal cells isolated from the rat epididymal epithelium.
    Klinefelter GR; Amann RP
    Biol Reprod; 1980 Jun; 22(5):1149-54. PubMed ID: 7417648
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates.
    Bruchovsky N; Rennie PS; Batzold FH; Goldenberg SL; Fletcher T; McLoughlin MG
    J Clin Endocrinol Metab; 1988 Oct; 67(4):806-16. PubMed ID: 2458378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: The testosterone 5alpha-reductase of human hyperplastic prostate.
    Wallace AM; Grant JK
    J Endocrinol; 1975 Nov; 67(2):10P-11P. PubMed ID: 54402
    [No Abstract]   [Full Text] [Related]  

  • 19. Sex-specific action of antiandrogens on androgen induced changes in hepatic microsomal 3 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase activity in the rat.
    Lax ER; Schriefers H
    Acta Endocrinol (Copenh); 1981 Oct; 98(2):261-6. PubMed ID: 6457494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate.
    Isaacs JT; Brendler CB; Walsh PC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):139-46. PubMed ID: 6183287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.